Literature DB >> 24989251

Correlations between depression behaviors and sleep parameters after repeated corticosterone injections in rats.

Zi-Jun Wang1, Bin Yu, Xue-Qiong Zhang, Zhao-Fu Sheng, Sheng-Jie Li, Yuan-Li Huang, Qing Cao, Xiang-Yu Cui, Su-Ying Cui, Yong-He Zhang.   

Abstract

AIM: Disrupted sleep may be a prodromal symptom or a predictor of depressive disorders. In this study we investigated the relationship between depression symptoms and disrupted sleep using a novel model of stress-mimicked sleep disorders in rats.
METHODS: SD rats were injected with corticosterone (10, 20 or 40 mg/kg, sc) or vehicle for 7 d. Their sleep-wake behavior was monitored through implanted EEG and EMG electrodes. Their depressive behaviors were assessed using forced swim test, open field test and sucrose preference test.
RESULTS: The corticosterone-treated rats showed significantly reduced sleep time, disinhibition of rapid-eye-movement (REM) sleep and altered power spectra during non-REM sleep. All depressive behavioral tests did not show significant difference across the groups. However, individual correlation analysis revealed statistically significance: the immobility time (despair) was negatively correlated with REM sleep latency, slow wave sleep (SWS) time ratio, SWS bouts and delta power density, and it was positively correlated with REM sleep bouts and beta power density. Meanwhile, sucrose preference (anhedonia) was positively correlated with total sleep time and light sleep bouts, and it was negatively correlated with the REM sleep time ratio.
CONCLUSION: In stress-mimicked rats, sleep disturbances are a predictor of depressive disorders, and certain symptoms of depression may be related to the disruption of several specific sleep parameters.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24989251      PMCID: PMC4088289          DOI: 10.1038/aps.2014.44

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  44 in total

1.  Neuronal excitability modulation over the sleep cycle: a structural and mathematical model.

Authors:  R W McCarley; J A Hobson
Journal:  Science       Date:  1975-07-04       Impact factor: 47.728

2.  An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress.

Authors:  M Papp; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Insomnia as a predictor of depression: do insomnia subtypes matter?

Authors:  Wilfred R Pigeon
Journal:  Sleep       Date:  2010-12       Impact factor: 5.849

4.  Persistent effects of antidepressants: EEG sleep studies in depressed patients during maintenance treatment.

Authors:  D J Kupfer; C L Ehlers; E Frank; V J Grochocinski; A B McEachran; A Buhari
Journal:  Biol Psychiatry       Date:  1994-05-15       Impact factor: 13.382

5.  Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults.

Authors:  N Breslau; T Roth; L Rosenthal; P Andreski
Journal:  Biol Psychiatry       Date:  1996-03-15       Impact factor: 13.382

6.  Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor.

Authors:  Sarah A Johnson; Neil M Fournier; Lisa E Kalynchuk
Journal:  Behav Brain Res       Date:  2005-12-28       Impact factor: 3.332

7.  Orbitofrontal cortex function and structure in depression.

Authors:  Wayne C Drevets
Journal:  Ann N Y Acad Sci       Date:  2007-09-13       Impact factor: 5.691

8.  Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia.

Authors:  Rachel Manber; Jack D Edinger; Jenna L Gress; Melanie G San Pedro-Salcedo; Tracy F Kuo; Tasha Kalista
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

Review 9.  Pathology of sleep, hormones and depression.

Authors:  A Steiger; M Dresler; M Kluge; P Schüssler
Journal:  Pharmacopsychiatry       Date:  2013-04-18       Impact factor: 5.788

10.  Risk markers for depression in adolescents: sleep and HPA measures.

Authors:  Uma Rao; Constance L Hammen; Russell E Poland
Journal:  Neuropsychopharmacology       Date:  2009-03-04       Impact factor: 7.853

View more
  6 in total

1.  Glucocorticoid receptors in the locus coeruleus mediate sleep disorders caused by repeated corticosterone treatment.

Authors:  Zi-Jun Wang; Xue-Qiong Zhang; Xiang-Yu Cui; Su-Ying Cui; Bin Yu; Zhao-Fu Sheng; Sheng-Jie Li; Qing Cao; Yuan-Li Huang; Ya-Ping Xu; Yong-He Zhang
Journal:  Sci Rep       Date:  2015-03-24       Impact factor: 4.379

2.  Two combined amino acids promote sleep activity in caffeine-induced sleepless model systems.

Authors:  Ki-Bae Hong; Yooheon Park; Hyung Joo Suh
Journal:  Nutr Res Pract       Date:  2018-04-10       Impact factor: 1.926

3.  Research into an Association between Anhedonia and Decreased REM Latency in Moderately to Severely Depressed Patients.

Authors:  Laurie Nizet; Xavier Montana; Jean-Pol Lanquart; Gwenolé Loas
Journal:  Sleep Disord       Date:  2018-07-02

Review 4.  Sleep Disturbances and Depression Are Co-morbid Conditions: Insights From Animal Models, Especially Non-human Primate Model.

Authors:  Meng Li; Jieqiong Cui; Bonan Xu; Yuanyuan Wei; Chenyang Fu; Xiaoman Lv; Lei Xiong; Dongdong Qin
Journal:  Front Psychiatry       Date:  2022-01-25       Impact factor: 4.157

5.  Different neural circuitry is involved in physiological and psychological stress-induced PTSD-like "nightmares" in rats.

Authors:  Bin Yu; Su-Ying Cui; Xue-Qiong Zhang; Xiang-Yu Cui; Sheng-Jie Li; Zhao-Fu Sheng; Qing Cao; Yuan-Li Huang; Ya-Ping Xu; Zhi-Ge Lin; Guang Yang; Jin-Zhi Song; Hui Ding; Yong-He Zhang
Journal:  Sci Rep       Date:  2015-11-04       Impact factor: 4.379

6.  Melanin-Concentrating Hormone (MCH) and MCH-R1 in the Locus Coeruleus May Be Involved in the Regulation of Depressive-Like Behavior.

Authors:  Hui Ye; Xiang-Yu Cui; Hui Ding; Su-Ying Cui; Xiao Hu; Yu-Tong Liu; Hui-Ling Zhao; Yong-He Zhang
Journal:  Int J Neuropsychopharmacol       Date:  2018-12-01       Impact factor: 5.176

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.